Item 16. Form 10-K Summary
28K characters. Original on sec.gov ·
Item 16. Form 10-K Summary
None.
| INDEX TO EXHIBITS | |||||||||||
| Exhibit No. | Description | ||||||||||
| (97) | Policy Relating to Recovery of Erroneously Awarded Compensation. | ||||||||||
| 97.1 | Air Products and Chemicals, Inc. Compensation Recoupment Policy and Supplemental Executive Officer Recoupment Policy, effective as of 1 October 2023. (Filed as Exhibit 97.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended 30 September 2023.)* | ||||||||||
| (101) | Interactive Data Files. | ||||||||||
| 101.INS | Inline XBRL Instance Document. The XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. | ||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||||||||
| 104 | Cover Page Interactive Data File, formatted in Inline XBRL (included in Exhibit 101). |
| * | Previously filed as indicated and incorporated herein by reference. Exhibits incorporated by reference are located in SEC File No. 001-04534 unless otherwise indicated. | ||||
| ** | Long-term debt instruments under which the total amount of securities authorized does not exceed 10 percent of our consolidated total assets are not filed as exhibits to this Annual Report on Form 10-K. We will furnish a copy of these agreements to the Securities and Exchange Commission upon request. | ||||
| † | Indicates management contract or compensatory arrangement. | ||||
| †† | The certification attached as Exhibit 32.1 that accompanies this Annual Report on Form 10-K, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of Air Products and Chemicals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing. |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AIR PRODUCTS AND CHEMICALS, INC. | |||||
| (Registrant) | |||||
| By: | /s/ Melissa N. Schaeffer | ||||
| Melissa N. Schaeffer Executive Vice President and Chief Financial Officer (Principal Financial Officer) | |||||
| Date: | 19 November 2026 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature and Title | Date | |||||||
| /s/ Eduardo F. Menezes | 19 November 2026 | |||||||
| Eduardo F. Menezes Chief Executive Officer and Director (Principal Executive Officer) | ||||||||
| /s/ Melissa N. Schaeffer | 19 November 2026 | |||||||
| Melissa N. Schaeffer Executive Vice President and Chief Financial Officer (Principal Financial Officer) | ||||||||
| /s/ William J. Pellicciotti | 19 November 2026 | |||||||
| William J. Pellicciotti Vice President, Controller, and Chief Accounting Officer (Principal Accounting Officer) | ||||||||
| * | 19 November 2026 | |||||||
| Tonit M. Calaway Director | ||||||||
| * | 19 November 2026 | |||||||
| Andrew W. Evans Director | ||||||||
| * | 19 November 2026 | |||||||
| Jessica Trocchi Graziano Director |
| Signature and Title | Date | |||||||
| * | 19 November 2026 | |||||||
| Paul C. Hilal Director | ||||||||
| * | 19 November 2026 | |||||||
| Bhavesh V. Patel Director | ||||||||
| * | 19 November 2026 | |||||||
| Dennis H. Reilley Director Vice Chairman of the Board of Directors | ||||||||
| * | 19 November 2026 | |||||||
| Wayne T. Smith Director Chairman of the Board of Directors | ||||||||
| * | 19 November 2026 | |||||||
| Alfred Stern Director | ||||||||
| * | 19 November 2026 | |||||||
| Howard Ungerleider Director |
| * | Matthew Lepore, Executive Vice President, General Counsel, Chief Compliance Officer and Secretary, by signing his name hereto, does sign this document on behalf of the above noted individuals, pursuant to a power of attorney duly executed by such individuals, which is filed with the Securities and Exchange Commission herewith. |
| /s/ Matthew Lepore | ||
| Matthew Lepore | ||
| Executive Vice President, General Counsel, Chief Compliance Officer and Secretary | ||
| Date: 19 November 2026 |
Previous: Item 15. Exhibits and Financial Statement Schedules